multiomic profile to assess genetic and environmental risk factiors: Genomic, epigenetic, proteomic, microbiome, immunology, biomarker, metabolite, pesticide, metal, and metalloid investigations will be conducted. The twins will be followed longitudinally from a clinical perspective, with biological sample collections to assess discordance and identify early disease signatures in unaffected individuals.
The goal of this study is to learn from discordant twins affected by Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia the contribution of genetic background versus environmental exposure. The main questions it aims to answer is:
* How far does the genetic background explain the onset of ALS/FTD in discordant twins?
* Which environmental factors and events occurring in post-fetal life influence the onset or progression of this neurodegenerative condition? Participants with ALS and/or FTD with a monozygotic or dizygotic twin willing to contribute to this research will be followed up for two years by specialized Motor Neuron Disorders centers in Italy, donating biological specimen for -omic sciences analysis, and checking out if prodromal signs/symptoms of these two conditions will develop during time.
| Facility | City | Region | Status |
|---|---|---|---|
| Azienda Ospedaliero-Universitaria di Modena | Modena | Italy | Recruiting |
| Azienda Ospedaliero-Universitaria Policlinico P. Giaccone di Palermo | Palermo | Italy | Recruiting |
| Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino | Torino | Italy | Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06595212 on ClinicalTrials.gov ↗ ← All trials in Italy